Blog
RSS FeedPosted by Michael Wonder on 22 Mar 2023
HTA reform gets underway – terms of reference released today
22 March 2023 - Medicines Australia acknowledges the Health Technology Assessment Review Terms of Reference – released today – and ...
Posted by Michael Wonder on 22 Mar 2023
Terms of reference for the Health Technology Assessment Policy and Methods Review
22 March 2023 - The terms of reference for the Health Technology Assessment Policy and Methods Review is now available. ...
Posted by Michael Wonder on 14 Mar 2023
CEO’s appointment to HTA Review Reference Committee
15 March 2023 - CEO of Medicines Australia, Elizabeth de Somer, has been appointed as the medicines industry representative on ...
Posted by Michael Wonder on 09 Mar 2023
Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (March 2023)
9 March 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 13 February 2023. ...
Posted by Michael Wonder on 03 Mar 2023
PHARMAC releases final response to review
3 March 2023 - "There are 30 actions we committed to in the interim response – these are part of ...
Posted by Michael Wonder on 28 Feb 2023
“Killing time” one year on, still no final response from PHARMAC to the independent review
28 February 2023 - Today marks one year since the PHARMAC Review was delivered to then Health Minister Andrew Little. ...
Posted by Michael Wonder on 20 Feb 2023
ABPI response to Lord O'Shaughnessy review
20 February 2023 - The Office for Life Sciences has today announced that Lord James O’Shaughnessy will conduct a review ...
Posted by Michael Wonder on 10 Feb 2023
Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (February 2023)
10 February 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 27 January 2023. ...
Posted by Michael Wonder on 05 Feb 2023
Release of the Strengthening Medicare Taskforce Report
3 February 2023 - The Strengthening Medicare Taskforce Report is now available. ...
Posted by Michael Wonder on 03 Feb 2023
Strengthening Medicare for the future
3 February 2023 - The Albanese Government has released the Strengthening Medicare Taskforce report. ...
Posted by Michael Wonder on 02 Feb 2023
‘Enough sickness’ to share GP load among pharmacists, nurses
2 February 2023 - Pharmacy Guild of Australia president Trent Twomey says there is enough “demand and sickness” to allow ...
Posted by Michael Wonder on 31 Jan 2023
FDA may not always require post-approval trials to be enrolled before accelerated approvals
30 January 2023 - A FDa official on Monday gave more clues for how the agency plans to wield new authority ...
Posted by Michael Wonder on 31 Jan 2023
Options for a reformed Prostheses List pre-listing assessment framework and governance structure
31 January 2023 - This report provides a framework and proposes options for governance that would align the Prostheses List processes ...
Posted by Michael Wonder on 26 Jan 2023
Draft methods (version 7.0): IQWiG is extending the comment period
26 January 2023 - The new deadline is 28 February 2023. ...
Posted by Michael Wonder on 25 Jan 2023
The 4 biggest questions about the FDA’s forthcoming changes to accelerated approvals
25 January 2023 - Congress just boosted the FDA’s authority over the post-market clinical trials that are a condition of ...